undergoes a change of control, at a repurchase price of 101% of the principal amount plus accrued and unpaid interest. Additionally, an event of default may result in the acceleration of the maturity of the
4.212
% Notes and
4.319
% Notes.
2.375% Senior Notes Due 2030, 3.924% Senior Notes Due 2032 and 4.393% Senior Notes Due 2052
The
2.375
% Notes,
3.924
% Notes and
4.393
% Notes are general unsecured senior obligations of the Company with semi-annual fixed interest payments due on June 1 and December 1.
As of March 29, 2025, the Company was in compliance with the covenants associated with its debt.
Revolving Credit Facility
The Company has $
3.0
billion available under an unsecured revolving credit facility that expires on April 29, 2027. During the three months ended March 29, 2025, the Company did not borrow under the revolving credit facility and as of March 29, 2025 and December 28, 2024, the Company had no outstanding borrowings under the revolving credit facility. As of March 29, 2025, the Company was in compliance with the covenants under the revolving credit facility.
Commercial Paper Program
The Company has a commercial paper program under which it can issue unsecured commercial paper notes up to a principal amount of $
3.0
billion at any time with maturities of up to 397 days from the date of issue. The commercial paper will be sold at a discount from par or, alternatively, will be sold at par and bear interest at rates that will vary based on market conditions at the time of the issuance. During the three months ended March 29, 2025, the Company issued $
950
million in aggregate principal amount of commercial paper, which was outstanding as of March 29, 2025. The outstanding commercial paper have a weighted-average interest rate of 4.35% with maturities of up to 60 days. As of December 28, 2024, the Company had no commercial paper outstanding. Outstanding commercial paper is reported within Short-term borrowings in the Condensed Consolidated Balance Sheets.
15
Table of Contents
NOTE 8 –
Financial Instruments
Financial Instruments Recorded at Fair Value on a Recurring Basis
Deferred compensation plan investments are primarily mutual fund investments held in a Rabbi trust established to maintain the Company’s executive deferred compensation plan.
The following is a summary of cash equivalents and short-term investments:
As of March 29, 2025 and December 28, 2024, the Company did not have material available-for-sale debt securities which have been in a continuous unrealized loss position of more than twelve months.
16
Table of Contents
The contractual maturities of investments classified as available-for-sale are as follows:
Financial Instruments Not Recorded at Fair Value
The carrying amounts and estimated fair values of the Company’s long-term debt are as follows:
The estimated fair value of the Company’s long-term debt is based on Level 2 inputs of quoted prices for the Company’s debt and comparable instruments in inactive markets.